gimli
LOTUSEYE stock analysis context
LOTUS EYE HOSP & INST L Stock Context for AI Screening
LOTUS EYE HOSP & INST L is a small-cap stock in Healthcare. This page summarizes key screening signals for LOTUS EYE HOSP & INST L, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Open interactive LOTUSEYE stock pagePrice
₹110.04
1W return
+0.57%
1M return
-7.43%
3M return
+2.21%
6M return
+4.21%
1Y return
+54.01%
Market cap
₹228.84 cr
PE
352.07
PB
3.78
ROE
n/a
ROCE
n/a
RSI
48.94
Turnover
₹0.09 cr
Why it can matter in screens
- Momentum: LOTUSEYE is trend mixed or unavailable; RSI is 48.94.
- Returns: 1D +1.54%, 1W +0.57%, 1M -7.43%, 3M +2.21%, 1Y +54.01%.
- Trend levels: 52W high ₹141.38, 52W low ₹70.02, off high -22.17%.
- Liquidity: latest turnover is ₹0.09 cr; volume vs 20D is +1.02%.
- Valuation/profitability: PE 352.07, PB 3.78, ROE n/a, ROCE n/a.
- Growth: 3Y sales CAGR n/a, 3Y profit CAGR n/a.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2025-12-31 | 13.55 cr | 0.89 cr | -0.26 cr | -0.13 |
| 2025-09-30 | 13.04 cr | 1.04 cr | 0.12 cr | 0.06 |
| 2025-06-30 | 13.52 cr | 1.67 cr | 0.54 cr | 0.26 |
| 2025-03-31 | 10.55 cr | 0.94 cr | 0.25 cr | nan |
| 2024-12-31 | 12.25 cr | 1.01 cr | -0.24 cr | -0.11 |
| 2024-09-30 | n/a | n/a | n/a | 0.05 |
Annual income statement
No recent data available.
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2025-09-30 | 71.51 cr | 1.48 cr | 4.80 cr | 60.62 cr |
| 2025-03-31 | 69.57 cr | 2.01 cr | 3.43 cr | 60.00 cr |
| 2024-09-30 | 70.07 cr | 0.31 cr | 2.99 cr | 60.11 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2025-12-31 | n/a | n/a | n/a |
| 2025-09-30 | n/a | n/a | n/a |
| 2025-06-30 | n/a | n/a | n/a |
| 2025-03-31 | n/a | n/a | n/a |
| 2024-12-31 | n/a | n/a | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-03-31 | +40.14% | +0.00% | +0.02% | +0.00% | +59.84% | +0.00% |
| 2025-12-31 | +39.67% | +0.01% | +2.46% | +0.00% | +57.86% | +0.00% |
| 2025-09-30 | +40.64% | +0.00% | +0.02% | +0.00% | +59.33% | +0.00% |
| 2025-06-30 | +40.39% | +0.01% | +0.02% | +0.00% | +59.58% | +0.00% |
| 2025-03-31 | +40.22% | +0.00% | +0.04% | +0.00% | +59.74% | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 429,121.06 cr | 40.824543 | +15.06% | +7.26% |
| DIVISLAB | DIVI S LABORATORIES LTD | 174,585.42 cr | 68.707369 | +17.81% | +0.71% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 147,849.87 cr | 68.354079 | +29.94% | +39.35% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 119,204.71 cr | 64.295958 | +23.21% | +21.70% |
| CIPLA | CIPLA LTD | 111,088.72 cr | 29.624450 | +12.91% | -6.65% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 108,331.15 cr | 21.874917 | +20.44% | +16.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 105,181.70 cr | 24.542479 | +13.88% | +1.20% |
| LUPIN | LUPIN LIMITED | 103,385.66 cr | 22.341869 | +29.22% | +15.72% |
Try these prompts
- Analyze LOTUS EYE HOSP & INST L with valuation, momentum and industry peers
- Compare LOTUSEYE with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare LOTUSEYE with other Healthcare stocks
Data snapshot: 2026-06-03. Not investment advice.